"A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LY2951742 WITH A LONG-TERM OPEN-LABEL EXTENSION IN PATIENTS WITH CHRONIC CLUSTER HEADACHE."

Registry ID

I5Q-MC-CGAM

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

ELI LILLY CANADA INC

Start date

2016-03-03

Completion date

2019-08-14

Last update

2015-06-25

Conditions

• CHRONIC CLUSTER HEADACHE

Related clinical trials

• A MULTICENTER, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EXPLORE THE LONG-TERM SAFETY OF TEV-48125 FOR THE PREVENTION OF CLUSTER HEADACHE
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED, PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF 2 DOSE REGIMENS (INTRAVENOUS/SUBCUTANEOUS AND SUBCUTANEOUS) OF TEV-48125 VERSUS PLACEBO FOR THE PREVENTION OF CHRONIC CLUSTER HEADACHE

View on source registry